Plain-English translation of NCT07301255 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Asthma research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing a new medication called to see if it can help adults whose asthma is not fully controlled even while taking standard inhaled treatments. You would take the medication (or a placebo) once a day by mouth for 12 weeks, and researchers would carefully track how safe it is and whether it helps reduce asthma symptoms and improve how well your lungs work.
Many people with moderate to severe asthma still struggle with their symptoms and asthma attacks despite using the standard treatments available today. This trial is exploring whether this new medication could offer better control and improve quality of life for patients like you.
You likely qualify if…
You likely don't qualify if…
After an initial screening visit to confirm you qualify, you would visit the research clinic roughly once weekly for 12 weeks. At each visit, researchers would check your vital signs, ask about your asthma symptoms, and perform breathing tests. You would take your assigned medication (either or a placebo) once daily at home, and the team would draw blood periodically to measure how the medication is working in your body and to monitor your safety.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
United States